Search Results for compound
Searching compound for 1-Octanol returned 36137 results.
Displaying compounds 651 - 675 of 36137 in total
(2-aminoethoxy)[(2R)-2,3-bis(octadec-11-enoyloxy)propoxy]phosphinic acid
Matched synonyms: … PE(18:1/18:1) ... GPEtn(18:1/18:1) ... Phophatidylethanolamine(18:1/18:1) …
Matched name: … PE(18:1(11Z)/18:1(11Z)) …
Matched description: … PE(18:1(11Z)/18:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). ... PE(18:1(11Z)/18:1(11Z)), in particular, consists of two chains of vaccenic acid at the C-1 and C-2 positions ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
Matched name: … PE(18:1(11Z)/18:1(11Z)) …
Matched description: … PE(18:1(11Z)/18:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). ... PE(18:1(11Z)/18:1(11Z)), in particular, consists of two chains of vaccenic acid at the C-1 and C-2 positions ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
(2-aminoethoxy)[(2R)-2-(docos-13-enoyloxy)-3-(octadec-11-enoyloxy)propoxy]phosphinic acid
Matched synonyms: … PE(18:1/22:1) ... GPEtn(18:1/22:1) ... Phophatidylethanolamine(18:1/22:1) …
Matched name: … PE(18:1(11Z)/22:1(13Z)) …
Matched description: … PE(18:1(11Z)/22:1(13Z)) is a phosphatidylethanolamine (PE or GPEtn). ... PE(18:1(11Z)/22:1(13Z)), in particular, consists of one chain of vaccenic acid at the C-1 position and ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
Matched name: … PE(18:1(11Z)/22:1(13Z)) …
Matched description: … PE(18:1(11Z)/22:1(13Z)) is a phosphatidylethanolamine (PE or GPEtn). ... PE(18:1(11Z)/22:1(13Z)), in particular, consists of one chain of vaccenic acid at the C-1 position and ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
(2-aminoethoxy)[(2R)-3-(octadec-11-enoyloxy)-2-(tetracos-15-enoyloxy)propoxy]phosphinic acid
Matched synonyms: … PE(18:1/24:1) ... GPEtn(18:1/24:1) ... Phophatidylethanolamine(18:1/24:1) …
Matched name: … PE(18:1(11Z)/24:1(15Z)) …
Matched description: … PE(18:1(11Z)/24:1(15Z)) is a phosphatidylethanolamine (PE or GPEtn). ... PE(18:1(11Z)/24:1(15Z)), in particular, consists of one chain of vaccenic acid at the C-1 position and ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
Matched name: … PE(18:1(11Z)/24:1(15Z)) …
Matched description: … PE(18:1(11Z)/24:1(15Z)) is a phosphatidylethanolamine (PE or GPEtn). ... PE(18:1(11Z)/24:1(15Z)), in particular, consists of one chain of vaccenic acid at the C-1 position and ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
(2-aminoethoxy)[(2R)-3-(icos-11-enoyloxy)-2-(tetradec-9-enoyloxy)propoxy]phosphinic acid
Matched synonyms: … PE(20:1/14:1) ... GPEtn(20:1/14:1) ... Phophatidylethanolamine(20:1/14:1) …
Matched name: … PE(20:1(11Z)/14:1(9Z)) …
Matched description: … PE(20:1(11Z)/14:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). ... PE(20:1(11Z)/14:1(9Z)), in particular, consists of one chain of eicosenoic acid at the C-1 position and ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
Matched name: … PE(20:1(11Z)/14:1(9Z)) …
Matched description: … PE(20:1(11Z)/14:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). ... PE(20:1(11Z)/14:1(9Z)), in particular, consists of one chain of eicosenoic acid at the C-1 position and ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
(2-aminoethoxy)[(2R)-2-(docos-13-enoyloxy)-3-(icos-11-enoyloxy)propoxy]phosphinic acid
Matched synonyms: … PE(20:1/22:1) ... GPEtn(20:1/22:1) ... Phophatidylethanolamine(20:1/22:1) …
Matched name: … PE(20:1(11Z)/22:1(13Z)) …
Matched description: … PE(20:1(11Z)/22:1(13Z)) is a phosphatidylethanolamine (PE or GPEtn). ... PE(20:1(11Z)/22:1(13Z)), in particular, consists of one chain of eicosenoic acid at the C-1 position ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
Matched name: … PE(20:1(11Z)/22:1(13Z)) …
Matched description: … PE(20:1(11Z)/22:1(13Z)) is a phosphatidylethanolamine (PE or GPEtn). ... PE(20:1(11Z)/22:1(13Z)), in particular, consists of one chain of eicosenoic acid at the C-1 position ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
(2-aminoethoxy)[(2R)-3-(docos-13-enoyloxy)-2-(octadec-11-enoyloxy)propoxy]phosphinic acid
Matched synonyms: … PE(22:1/18:1) ... GPEtn(22:1/18:1) ... Phophatidylethanolamine(22:1/18:1) …
Matched name: … PE(22:1(13Z)/18:1(11Z)) …
Matched description: … PE(22:1(13Z)/18:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). ... PE(22:1(13Z)/18:1(11Z)), in particular, consists of one chain of erucic acid at the C-1 position and ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
Matched name: … PE(22:1(13Z)/18:1(11Z)) …
Matched description: … PE(22:1(13Z)/18:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). ... PE(22:1(13Z)/18:1(11Z)), in particular, consists of one chain of erucic acid at the C-1 position and ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
(2-aminoethoxy)[(2R)-3-(tetracos-15-enoyloxy)-2-(tetradec-9-enoyloxy)propoxy]phosphinic acid
Matched synonyms: … PE(24:1/14:1) ... GPEtn(24:1/14:1) ... Phophatidylethanolamine(24:1/14:1) …
Matched name: … PE(24:1(15Z)/14:1(9Z)) …
Matched description: … PE(24:1(15Z)/14:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). ... PE(24:1(15Z)/14:1(9Z)), in particular, consists of one chain of nervonic acid at the C-1 position and ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
Matched name: … PE(24:1(15Z)/14:1(9Z)) …
Matched description: … PE(24:1(15Z)/14:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). ... PE(24:1(15Z)/14:1(9Z)), in particular, consists of one chain of nervonic acid at the C-1 position and ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
[(2R)-3-[(9Z)-hexadec-9-enoyloxy]-2-[(9Z)-octadec-9-enoyloxy]propoxy]({[(1s,3R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid
Matched synonyms: … 1-(9Z-Hexadecenoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-O-(1'-myo-inositol) ... 1-(9Z-hexadecenoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-(1'-myo-inositol) ... 1-Palmitoleoyl-2-oleoyl-sn-glycero-3-oinositol …
Matched name: … PI(16:1(9Z)/18:1(9Z)) …
Matched description: … PI(16:1(9Z)/18:1(9Z))is a phosphatidylinositol. ... Fatty acids containing 18 and 20 carbons are the most common.PI(16:1(9Z)/18:1(9Z)), in particular, consists ... of one 9Z-hexadecenoyl chain to the C-1 atom, and one 9Z-octadecenoyl to the C-2 atom. …
Matched name: … PI(16:1(9Z)/18:1(9Z)) …
Matched description: … PI(16:1(9Z)/18:1(9Z))is a phosphatidylinositol. ... Fatty acids containing 18 and 20 carbons are the most common.PI(16:1(9Z)/18:1(9Z)), in particular, consists ... of one 9Z-hexadecenoyl chain to the C-1 atom, and one 9Z-octadecenoyl to the C-2 atom. …
[(2R)-2-(icos-11-enoyloxy)-3-(octadec-9-enoyloxy)propoxy]({[(1s,3R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid
Matched synonyms: … 1-(9Z-Octadecenoyl)-2-(11-eicosenoyl)-sn-glycero-3-O-(1'-myo-inositol) ... 1-(9Z-octadecenoyl)-2-(11-eicosenoyl)-sn-glycero-3-phospho-(1'-myo-inositol) ... 1-Oleoyl-2-eicosenoyl-sn-glycero-3-oinositol …
Matched name: … PI(18:1(9Z)/20:1(11Z)) …
Matched description: … PI(18:1(9Z)/20:1(11Z)) is a phosphatidylinositol. ... PI(18:1(9Z)/20:1(11Z)), in particular, consists of one chain of oleic acid at the C-1 position and one ... PIs contain almost exclusively stearic acid at carbon 1 and arachidonic acid at carbon 2. …
Matched name: … PI(18:1(9Z)/20:1(11Z)) …
Matched description: … PI(18:1(9Z)/20:1(11Z)) is a phosphatidylinositol. ... PI(18:1(9Z)/20:1(11Z)), in particular, consists of one chain of oleic acid at the C-1 position and one ... PIs contain almost exclusively stearic acid at carbon 1 and arachidonic acid at carbon 2. …
[(2R)-3-(icos-11-enoyloxy)-2-(octadec-11-enoyloxy)propoxy]({[(1s,3R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid
Matched synonyms: … PI(20:1/18:1) ... PIno(20:1/18:1) ... Atidylinositol(20:1/18:1) …
Matched name: … PI(20:1(11Z)/18:1(11Z)) …
Matched description: … PI(20:1(11Z)/18:1(11Z)) is a phosphatidylinositol. ... PI(20:1(11Z)/18:1(11Z)), in particular, consists of one chain of eicosenoic acid at the C-1 position ... PIs contain almost exclusively stearic acid at carbon 1 and arachidonic acid at carbon 2. …
Matched name: … PI(20:1(11Z)/18:1(11Z)) …
Matched description: … PI(20:1(11Z)/18:1(11Z)) is a phosphatidylinositol. ... PI(20:1(11Z)/18:1(11Z)), in particular, consists of one chain of eicosenoic acid at the C-1 position ... PIs contain almost exclusively stearic acid at carbon 1 and arachidonic acid at carbon 2. …
{[(1R,3S)-3-({[(2R)-2-(hexadec-9-enoyloxy)-3-(octadec-11-enoyloxy)propoxy](hydroxy)phosphoryl}oxy)-2,4,5,6-tetrahydroxycyclohexyl]oxy}phosphonic acid
Matched synonyms: … PIP(18:1/16:1) ... Atidylinositol ate(18:1/16:1) ... PIP[3'](18:1(11Z)/16:1(9Z)) …
Matched name: … PIP(18:1(11Z)/16:1(9Z)) …
Matched description: … PIP(18:1(11Z)/16:1(9Z)) is a phosphatidylinositol phosphate. ... PIP(18:1(11Z)/16:1(9Z)), in particular, consists of one chain of vaccenic acid at the C-1 position and ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
Matched name: … PIP(18:1(11Z)/16:1(9Z)) …
Matched description: … PIP(18:1(11Z)/16:1(9Z)) is a phosphatidylinositol phosphate. ... PIP(18:1(11Z)/16:1(9Z)), in particular, consists of one chain of vaccenic acid at the C-1 position and ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
{[(1R,3S)-3-({[(2R)-2-(hexadec-9-enoyloxy)-3-(octadec-9-enoyloxy)propoxy](hydroxy)phosphoryl}oxy)-2,4,5,6-tetrahydroxycyclohexyl]oxy}phosphonic acid
Matched synonyms: … PIP[3'](18:1(9Z)/16:1(9Z)) ... 1-(9Z-Octadecenoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-O-(1'-myo-inositol-3'-ate) ... 1-(9Z-octadecenoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-(1'-myo-inositol-3'-phosphate) …
Matched name: … PIP(18:1(9Z)/16:1(9Z)) …
Matched description: … PIP(18:1(9Z)/16:1(9Z)) is a phosphatidylinositol phosphate. ... PIP(18:1(9Z)/16:1(9Z)), in particular, consists of one chain of oleic acid at the C-1 position and one ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
Matched name: … PIP(18:1(9Z)/16:1(9Z)) …
Matched description: … PIP(18:1(9Z)/16:1(9Z)) is a phosphatidylinositol phosphate. ... PIP(18:1(9Z)/16:1(9Z)), in particular, consists of one chain of oleic acid at the C-1 position and one ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
{[(1R,5S)-2,3,4,6-tetrahydroxy-5-({hydroxy[(2R)-2-(icos-11-enoyloxy)-3-(octadec-9-enoyloxy)propoxy]phosphoryl}oxy)cyclohexyl]oxy}phosphonic acid
Matched synonyms: … PIP(18:1/20:1) ... Atidylinositol ate(18:1/20:1) ... PIP[3'](18:1(9Z)/20:1(11Z)) …
Matched name: … PIP(18:1(9Z)/20:1(11Z)) …
Matched description: … PIP(18:1(9Z)/20:1(11Z)) is a phosphatidylinositol phosphate. ... PIP(18:1(9Z)/20:1(11Z)), in particular, consists of one chain of oleic acid at the C-1 position and one ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
Matched name: … PIP(18:1(9Z)/20:1(11Z)) …
Matched description: … PIP(18:1(9Z)/20:1(11Z)) is a phosphatidylinositol phosphate. ... PIP(18:1(9Z)/20:1(11Z)), in particular, consists of one chain of oleic acid at the C-1 position and one ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
{[(4S,6S)-2,3,5-trihydroxy-4-({hydroxy[(2R)-2-(octadec-11-enoyloxy)-3-(octadec-9-enoyloxy)propoxy]phosphoryl}oxy)-6-(phosphonooxy)cyclohexyl]oxy}phosphonic acid
Matched synonyms: … PIP2[3',4'](18:1(9Z)/18:1(11Z)) ... 1-(9Z-Octadecenoyl)-2-(11Z-octadecenoyl)-sn-glycero-3-O-(1'-myo-inositol-3',4'-bisate) ... 1-(9Z-octadecenoyl)-2-(11Z-octadecenoyl)-sn-glycero-3-phospho-(1'-myo-inositol-3',4'-bisphosphate) …
Matched name: … PIP2(18:1(9Z)/18:1(11Z)) …
Matched description: … PIP2(18:1(9Z)/18:1(11Z)) is a phosphatidylinositol bisphosphate. ... PIP2(18:1(9Z)/18:1(11Z)), in particular, consists of one chain of oleic acid at the C-1 position and ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
Matched name: … PIP2(18:1(9Z)/18:1(11Z)) …
Matched description: … PIP2(18:1(9Z)/18:1(11Z)) is a phosphatidylinositol bisphosphate. ... PIP2(18:1(9Z)/18:1(11Z)), in particular, consists of one chain of oleic acid at the C-1 position and ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
{[(4S,6S)-2,3,5-trihydroxy-4-({hydroxy[(2R)-2-(icos-11-enoyloxy)-3-(octadec-9-enoyloxy)propoxy]phosphoryl}oxy)-6-(phosphonooxy)cyclohexyl]oxy}phosphonic acid
Matched synonyms: … PIP2[3',4'](18:1(9Z)/20:1(11Z)) ... 1-(9Z-Octadecenoyl)-2-(11-eicosenoyl)-sn-glycero-3-O-(1'-myo-inositol-3',4'-bisate) ... 1-(9Z-octadecenoyl)-2-(11-eicosenoyl)-sn-glycero-3-phospho-(1'-myo-inositol-3',4'-bisphosphate) …
Matched name: … PIP2(18:1(9Z)/20:1(11Z)) …
Matched description: … PIP2(18:1(9Z)/20:1(11Z)) is a phosphatidylinositol bisphosphate. ... PIP2(18:1(9Z)/20:1(11Z)), in particular, consists of one chain of oleic acid at the C-1 position and ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
Matched name: … PIP2(18:1(9Z)/20:1(11Z)) …
Matched description: … PIP2(18:1(9Z)/20:1(11Z)) is a phosphatidylinositol bisphosphate. ... PIP2(18:1(9Z)/20:1(11Z)), in particular, consists of one chain of oleic acid at the C-1 position and ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
{[(3s,5S)-2,4-dihydroxy-3-({hydroxy[(2R)-3-(octadec-11-enoyloxy)-2-(octadec-9-enoyloxy)propoxy]phosphoryl}oxy)-5,6-bis(phosphonooxy)cyclohexyl]oxy}phosphonic acid
Matched synonyms: … PIP3[3',4',5'](18:1(11Z)/18:1(9Z)) ... 1-(11Z-Octadecenoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-O-(1'-myo-inositol-3',4',5'-trisate) ... 1-(11Z-octadecenoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-(1'-myo-inositol-3',4',5'-trisphosphate …
Matched name: … PIP3(18:1(11Z)/18:1(9Z)) …
Matched description: … PIP3(18:1(11Z)/18:1(9Z)) is a phosphatidylinositol trisphosphate. ... PIP3(18:1(11Z)/18:1(9Z)), in particular, consists of one chain of vaccenic acid at the C-1 position and ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
Matched name: … PIP3(18:1(11Z)/18:1(9Z)) …
Matched description: … PIP3(18:1(11Z)/18:1(9Z)) is a phosphatidylinositol trisphosphate. ... PIP3(18:1(11Z)/18:1(9Z)), in particular, consists of one chain of vaccenic acid at the C-1 position and ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
{[(3s,5S)-2,4-dihydroxy-3-({hydroxy[(2R)-2-(octadec-11-enoyloxy)-3-(octadec-9-enoyloxy)propoxy]phosphoryl}oxy)-5,6-bis(phosphonooxy)cyclohexyl]oxy}phosphonic acid
Matched synonyms: … PIP3[3',4',5'](18:1(9Z)/18:1(11Z)) ... 1-(9Z-Octadecenoyl)-2-(11Z-octadecenoyl)-sn-glycero-3-O-(1'-myo-inositol-3',4',5'-trisate) ... 1-(9Z-octadecenoyl)-2-(11Z-octadecenoyl)-sn-glycero-3-phospho-(1'-myo-inositol-3',4',5'-trisphosphate …
Matched name: … PIP3(18:1(9Z)/18:1(11Z)) …
Matched description: … PIP3(18:1(9Z)/18:1(11Z)) is a phosphatidylinositol trisphosphate. ... PIP3(18:1(9Z)/18:1(11Z)), in particular, consists of one chain of oleic acid at the C-1 position and ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
Matched name: … PIP3(18:1(9Z)/18:1(11Z)) …
Matched description: … PIP3(18:1(9Z)/18:1(11Z)) is a phosphatidylinositol trisphosphate. ... PIP3(18:1(9Z)/18:1(11Z)), in particular, consists of one chain of oleic acid at the C-1 position and ... have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 …
[(2S)-2,3-dihydroxypropoxy][(2R)-2-(hexadec-9-enoyloxy)-3-(octadec-9-enoyloxy)propoxy]phosphinic acid
Matched synonyms: … 1-(9Z-Octadecenoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-O-(1'-glycerol) ... 1-(9Z-octadecenoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-(1'-glycerol) ... 1-Oleoyl-2-palmitoleoyl-sn-glycero-3-oglycerol …
Matched name: … PG(18:1(9Z)/16:1(9Z)) …
Matched description: … PG(18:1(9Z)/16:1(9Z)) is a phosphatidylglycerol. ... PG(18:1(9Z)/16:1(9Z)), in particular, consists of one 9Z-octadecenoyl chain to the C-1 atom, and one ... glycerol 3-phosphate backbone esterified to either saturated or unsaturated fatty acids on carbons 1 …
Matched name: … PG(18:1(9Z)/16:1(9Z)) …
Matched description: … PG(18:1(9Z)/16:1(9Z)) is a phosphatidylglycerol. ... PG(18:1(9Z)/16:1(9Z)), in particular, consists of one 9Z-octadecenoyl chain to the C-1 atom, and one ... glycerol 3-phosphate backbone esterified to either saturated or unsaturated fatty acids on carbons 1 …
FDB028314
64091-91-4
4-[methyl(nitroso)amino]-1-(pyridin-3-yl)butan-1-one
Matched synonyms: … 4-(Methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone ... 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone ... 4-(Methylnitrosoamino)-1-(3-pyridyl)-1-butanone …
Matched name: … 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone …
Matched iupac: … 4-[methyl(nitroso)amino]-1-(pyridin-3-yl)butan-1-one …
Matched description: … 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) is a potent tobacco-specific nitrosamine in animals ... P450 1A2 catalyzed the formation of keto alcohol and 4-oxo-1-(3-pyridyl)-1-butanone (keto aldehyde) from …
Matched name: … 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone …
Matched iupac: … 4-[methyl(nitroso)amino]-1-(pyridin-3-yl)butan-1-one …
Matched description: … 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) is a potent tobacco-specific nitrosamine in animals ... P450 1A2 catalyzed the formation of keto alcohol and 4-oxo-1-(3-pyridyl)-1-butanone (keto aldehyde) from …
(2S,4S,5R)-2-{[(2R,3R,4S,5S,6R)-2-{[(2S,3R,4R,5R,6R)-2-{[(2R,3S,4R,5R,6S)-4-{[(2S,4S,5R)-2-carboxy-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy}-6-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(docos-13-enamido)-3-hydroxyoctadec-4-en-1-yl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-5-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-5-hydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)oxan-4-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Matched name: … Ganglioside GD1a (d18:1/22:1(13Z)) …
Matched iupac: … trihydroxypropyl]oxan-2-yl]oxy}-6-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(docos-13-enamido)-3-hydroxyoctadec-4-en-1- …
Matched description: … Ganglioside GD1a (d18:1/22:1(13Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GD1a (d18:1/22:1(13Z)) is a GD1a ganglioside, A glycosphingolipid ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
Matched iupac: … trihydroxypropyl]oxan-2-yl]oxy}-6-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(docos-13-enamido)-3-hydroxyoctadec-4-en-1- …
Matched description: … Ganglioside GD1a (d18:1/22:1(13Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GD1a (d18:1/22:1(13Z)) is a GD1a ganglioside, A glycosphingolipid ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
(2S,4S,5R)-2-{[(2R,3R,4S,5S,6R)-2-{[(2S,3R,4R,5R,6R)-2-{[(2R,3S,4R,5R,6S)-4-{[(2S,4S,5R)-2-carboxy-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy}-6-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(hexacos-17-enamido)-3-hydroxyoctadec-4-en-1-yl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-5-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-5-hydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)oxan-4-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Matched name: … Ganglioside GD1a (d18:1/26:1(17Z)) …
Matched iupac: … trihydroxypropyl]oxan-2-yl]oxy}-6-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(hexacos-17-enamido)-3-hydroxyoctadec-4-en-1- …
Matched description: … Ganglioside GD1a (d18:1/26:1(17Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GD1a (d18:1/26:1(17Z)) is a GD1a ganglioside, A glycosphingolipid ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
Matched iupac: … trihydroxypropyl]oxan-2-yl]oxy}-6-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(hexacos-17-enamido)-3-hydroxyoctadec-4-en-1- …
Matched description: … Ganglioside GD1a (d18:1/26:1(17Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GD1a (d18:1/26:1(17Z)) is a GD1a ganglioside, A glycosphingolipid ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
(2S,4S,5R)-2-{[(2S,3R,4R,5S,6R)-2-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(docos-13-enamido)-3-hydroxyoctadec-4-en-1-yl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-3-hydroxy-5-{[(2S,3R,4R,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)-4-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-6-(hydroxymethyl)oxan-4-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Matched name: … Ganglioside GM1 (d18:1/22:1(13Z)) …
Matched iupac: … 5R)-2-{[(2S,3R,4R,5S,6R)-2-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(docos-13-enamido)-3-hydroxyoctadec-4-en-1- …
Matched description: … Ganglioside GM1 (d18:1/22:1(13Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GM1 (d18:1/22:1(13Z)) is a GM1 Ganglioside. ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
Matched iupac: … 5R)-2-{[(2S,3R,4R,5S,6R)-2-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(docos-13-enamido)-3-hydroxyoctadec-4-en-1- …
Matched description: … Ganglioside GM1 (d18:1/22:1(13Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GM1 (d18:1/22:1(13Z)) is a GM1 Ganglioside. ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
(2S,4S,5R)-2-{[(2R,3S,4R,5R,6S)-3-{[(2S,3R,4R,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)oxan-2-yl]oxy}-6-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(docos-13-enamido)-3-hydroxyoctadec-4-en-1-yl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-5-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Matched name: … Ganglioside GM2 (d18:1/22:1(13Z)) …
Matched iupac: … oxopropyl)oxan-2-yl]oxy}-6-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(docos-13-enamido)-3-hydroxyoctadec-4-en-1- …
Matched description: … Ganglioside GM2 (d18:1/22:1(13Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GM2 (d18:1/22:1(13Z)) is a GM2 ganglioside. ... In the United States, about 1 in 27 to 1 in 30 Ashkenazi Jews is a recessive carrier. …
Matched iupac: … oxopropyl)oxan-2-yl]oxy}-6-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(docos-13-enamido)-3-hydroxyoctadec-4-en-1- …
Matched description: … Ganglioside GM2 (d18:1/22:1(13Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GM2 (d18:1/22:1(13Z)) is a GM2 ganglioside. ... In the United States, about 1 in 27 to 1 in 30 Ashkenazi Jews is a recessive carrier. …
(2S,4S,5R)-2-{[(2S,3R,4S,5S,6R)-2-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(docos-13-enamido)-3-hydroxyoctadec-4-en-1-yl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Matched name: … Ganglioside GM3 (d18:1/22:1(13Z)) …
Matched iupac: … 5R)-2-{[(2S,3R,4S,5S,6R)-2-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(docos-13-enamido)-3-hydroxyoctadec-4-en-1- …
Matched description: … Ganglioside GM3 (d18:1/22:1(13Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GM3 (d18:1/22:1(13Z)) is a GM3 ganglioside. ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
Matched iupac: … 5R)-2-{[(2S,3R,4S,5S,6R)-2-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-(docos-13-enamido)-3-hydroxyoctadec-4-en-1- …
Matched description: … Ganglioside GM3 (d18:1/22:1(13Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GM3 (d18:1/22:1(13Z)) is a GM3 ganglioside. ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
(2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2R,3S,4R,5R,6S)-3-{[(2S,3R,4R,5R,6R)-4-{[(2R,3R,4S,5S,6R)-4-{[(2S,4S,5R)-2-carboxy-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-hydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)oxan-2-yl]oxy}-6-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-{[(2S,3R)-3-hydroxy-2-(octadec-11-enamido)octadec-4-en-1-yl]oxy}-2-(hydroxymethyl)oxan-3-yl]oxy}-5-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-3-acetamido-4-hydroxyoxan-2-yl]-1,3-dihydroxypropan-2-yl]oxy}-3-acetamido-4-hydroxyoxan-2-yl]-1,3-dihydroxypropan-2-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Matched name: … Ganglioside GQ1c (d18:1/18:1(11Z)) …
Matched iupac: … (2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2R,3S,4R,5R,6S ... yl]oxy}-6-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-{[(2S,3R)-3-hydroxy-2-(octadec-11-enamido)octadec-4-en-1- …
Matched description: … Ganglioside GQ1c (d18:1/18:1(11Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GQ1c (d18:1/18:1(11Z)) is a GQ1c ganglioside, A glycosphingolipid ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
Matched iupac: … (2S,4S,5R)-2-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(1S,2R)-1-[(3R,4S,6S)-6-carboxy-6-{[(2R,3S,4R,5R,6S ... yl]oxy}-6-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-{[(2S,3R)-3-hydroxy-2-(octadec-11-enamido)octadec-4-en-1- …
Matched description: … Ganglioside GQ1c (d18:1/18:1(11Z)) is a ganglioside. ... [Wikipedia] Particularly, Ganglioside GQ1c (d18:1/18:1(11Z)) is a GQ1c ganglioside, A glycosphingolipid ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …